CONMED (NYSE:CNMD) Now Covered by Analysts at CL King

CL King started coverage on shares of CONMED (NYSE:CNMD – Get Rating) in a research report released on Monday, The Fly reports. The firm issued a buy rating and a $140.00 price objective on the stock. CNMD has been the topic of several other research reports. StockNews.com raised shares of CONMED from a sell rating […]

Related Keywords

United States ,Daniels Jonas ,Asia Pacific ,Stifel Nicolaus ,Piper Sandler ,Columbus Asset Advisors ,Proshare Advisors ,Exchange Traded Concepts ,Securities Exchange Commission ,Wells Fargo Company ,Needham Company ,Congress Wealth Management ,Northcrest Asset Manangement ,Get Rating ,Moderate Buy ,Exchange Commission ,Share Advisors ,Wealth Management ,Crest Asset Manangement ,Traded Concepts ,Middle East ,Conmed ,Nyse Cnmd ,Cnmd ,Medical ,Initiated Coverage ,Cl King ,